Coronavirus Update: How Should Remdesivir Be Priced? ICER Are In Two Minds

Plus Moderna and Daiichi Sankyo Updates

 
• By Scrip Team

Independent drug cost watchdog updates its twin pricing estimates for Gilead's drug - but dexamethasone could tip the balance again.

Vials_Remdesivir
Gilead will be heartened by the 'cost recovery' model, but new dexamethasone data is likely to have the biggest impact.

More from Business

More from Scrip